Recipharm

Unlocking our sites | With 39 years of experience, our Masate facility is recognised as one of Recipharm's leading sterile manufacturing locations. Supporting over 43 markets worldwide, we take pride in manufacturing more than 80 commercial products, each adhering to the highest quality standards. Specialising in injectables, the facility offers advanced lyophilisation services and liquid filling in vials and ampoules, ensuring tailored solutions for our clients. Discover how we can meet your fill and finish needs, both today and in the future: https://lnkd.in/dTWJ7aAx #CDMO #Sterilefill #Fillfinish #Lyophilization

The global biologics market is growing and developers are exploring alternative container formats for their sterile drug products. As each container format has different characteristics and advantages, careful consideration is required to optimise the performance of biologics products and deliver innovative treatments to patients. In our latest piece with BioProcess International, Vincenza Pironti, Ph.D., MBA Pironti, Head of Business Development at Recipharm explores the key considerations when selecting sterile container formats: https://lnkd.in/dsWQmk6y #BFS #PFS #Fillfinish #Biologics

A pioneering biotech dedicated to developing oncolytic adenovirus therapies had one year to deliver its groundbreaking flagship product to first-in-human clinical trials. Failure to do so risked potential investment consequences and could have prevented the therapy from making it to market. Find out how our experts in oncolytic viruses helped the biotech overcome critical challenges to achieving these accelerated timelines to deliver their therapy on schedule. https://lnkd.in/d7ipxhre #OncolyticViruses #RareDisease #OVManufacturing

Our Pianezza facility plays an important role on the journey to lowering CO2 emissions through innovative e-transport solutions together with, UCB, and their carrier, Green Logistics by Galliker We are very proud that our client chose us to take part in the test run, to transport pharmaceutical products between UCB Farchim SA in Bulle, Switzerland, and Recipharm in Pianezza, Italy, saving an impressive 842 kg of CO2 emissions. This collaboration highlights our shared commitment to reducing CO2 emissions and achieving the goals set as members of the SBT initiative. Read the full article here: https://lnkd.in/dapES4Ni https://lnkd.in/dfU6pRjv

EVENT | We are excited to announce that Balasubramaniam Jagdish, our Vice President of Formulation Development, will be participating in the CRS 2024 Annual Meeting and Expo, which will take place from July 8-12 in Bologna, Italy. Balasubramaniam will be presenting a poster on a case study involving a fixed-dose combination of Ciprofloxacin and Celecoxib as an investigational drug for Amyotrophic Lateral Sclerosis (ALS) patients. He will discuss how Recipharm developed a controlled-release monolithic tablet dosage form consisting of both drugs. We look forward to connecting with other professionals in the field. If you are attending the meeting, please feel free to reach out to Balasubramaniam Jagdish before or during the event. #CSR #formulationdevelopment #OSD #CDMO

✨Heading to CPHI Milan?✨ We offer you a unique opportunity to visit our advanced manufacturing facilities, Masate and Pianezza for extensive site tours. 🏭Masate A leader in sterile manufacturing with 39 years of expertise, producing for over 43 markets. Specializes in advanced lyophilisation and sterile liquid filling. 🏭Pianezza Renowned for versatile manufacturing of oral liquids and extensive packaging options, including analytical services and QP release. Register today and learn how Recipharm can take your product to market! https://lnkd.in/d-qkrD3S CPHI will be held from October 8-10. It's time to start scheduling your meetings. Please contact us to arrange your meeting soon, we look forward to seeing you there! #CPHIMilan #CDMO #Fillfinish #OSD

Excited to share Recipharm's cutting-edge advancements in pharma analytical services, driven by our expert team and state-of-the-art technologies across Europe and India. Join us as we continue to enhance our product development capabilities, contributing to a healthier world. 🌟 Read our CEO Greg Behar's post below 👇   #ProductDevelopment #Pharmaceuticals #Innovation #GlobalReach #ExpertTeam

✨ A Lyophilisation partner you can trust 🤝 Our state-of-the-art lyophilisation services, backed by over 50 years of experience, ensure the highest quality and expert support throughout your journey. We offer rapid, scalable handling of sterile fill and finish projects with advanced freeze-drying technology that meets stringent regulatory standards. Our comprehensive in-house capabilities ensure a seamless transition from development to commercial production. 🚀💡 Learn more: https://lnkd.in/d5heVNBM #Lyophilization #fillfinish #AsepticFilling #CDMO

📢 The Biopharma Manufacturing Landscape is Evolving! Recently, ReciBioPharm's President Vikas Gupta sat down with European Pharmaceutical Review to discuss: - The rise of nucleic acid-based therapeutics and the unique manufacturing challenges they present - The push towards continuous manufacturing and its potential to revolutionise how we produce life-saving medicines - Technological requirements to advance manufacturing of ATMPs 🔗 Read the full article here: https://lnkd.in/dCRxhi9A Reach out today to discover how ReciBioPharm's expertise can assist you in navigating the complex journey of ATMP development. #biopharma #manufacturing #nucleicacids #continuousmanufacturing #CDMO

Routine inspections by the US FDA play a critical role in ensuring drug safety and quality for patients. Stringent regulations mean it’s rare for cGMP inspections of manufacturing facilities to be completed without any observations. Common pitfalls leading to observations include: ❌ Data integrity issues ❌ Deviating from written procedures ❌ Gaps in training or qualifications Read our latest insight to find out what strategies Recipharm adopted to ensure a successful inspection at its Bengaluru site without any observations: https://lnkd.in/dXx4wapr #FDAinspection #DrugManufacturing #RegulatoryCompliance #QualityControl